-
Why Trader’s Are Watching: Par Petroleum Corporation (NYSEMKT:PARR), Auspex Pharmaceuticals (NASDAQ:ASPX), Affymetrix Inc. (NASDAQ:AFFX), Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS)
Par Petroleum Corporation (NYSEMKT:PARR) announced that it has appointed Joseph Israel to be its new President and Chief Executive Officer effective January 5, 2015. Israel is the former Senior Vice President of Hunt Refining Company, and was Chief Operating Officer of Alon USA Energy. Par Petroleum Corporation (NYSEMKT:PARR) in last trading activity moved up 13.74%…
-
Stocks to Keep Eyes On: Web.com Group (NASDAQ:WWWW), ON Semiconductor Corp. (NASDAQ:ONNN), SL Green Realty (NYSE:SLG), Companhia Brasileira (NYSE:CBD), Affymetrix (NASDAQ:AFFX)
Web.com Group, Inc. (Nasdaq:WWWW), a leading provider of Internet services and online marketing solutions for small businesses, announced the appointment of Timothy P. Cost to its Board of Directors, effective immediately. Web.com Group, Inc. (NASDAQ:WWWW) in last trading activity moved down -4.57% to close at $17.95. Company weekly performance is 5.65% while its quarterly performance…
-
Mix Sector Stocks: Idera Pharmaceuticals (NASDAQ:IDRA), Auspex Pharmaceuticals (NASDAQ:ASPX), Wausau Paper Corp. (NYSE:WPP), Affymetrix Inc. (NASDAQ:AFFX), China Automotive Systems (NASDAQ:CAAS)
On 2 December Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced new preclinical data that showed cancer immunotherapy with intratumoral injections of IMO-2055 and ipilimumab demonstrated potent and systemic anti-tumor activity in multiple preclinical cancer models. IMO-2055 is a synthetic oligonucleotide-based agonist of Toll-like receptor (TLR) 9 discovered and developed by Idera. Ipilimumab is a checkpoint inhibitor targeting…
-
Stock Highlights: Repligen Corporation (NASDAQ:RGEN), Cavium (NASDAQ:CAVM), Broadridge Financial Solutions (NYSE:BR), Arbor Realty Trust Inc. (NYSE:ABR), Affymetrix Inc. (NASDAQ:AFFX)
Repligen (NASDAQ:RGEN) Director Michael A. Griffith sold 23,342 shares of Repligen stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $22.90, for a total transaction of $534,531.80. Following the transaction, the director now directly owns 1,932 shares of the company’s stock, valued at approximately $44,243.…
-
Investor’s Alert – Apple Inc. (NASDAQ:AAPL), Affymetrix, Inc. (NASDAQ:AFFX), Gilead Sciences, Inc. (NASDAQ:GILD), Kandi Technologies Group Inc (NASDAQ:KNDI)
Apple Inc. (NASDAQ:AAPL) was downgraded by equities research analysts at Societe Generale from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports. Shares of Apple Inc. (NASDAQ:AAPL) closed at $540.67 in last trading session. Yesterday share price of the company was traded in the range of…